Related Experiment Videos
Lambda red-dependent growth and recombination of phage P22
Virology
|April 15, 1984
Summary
Researchers constructed plasmids expressing lambda recombination functions for controlled gene expression. The lambda bet and exo genes together efficiently substituted for the P22 recombination system in recA- hosts.
Area of Science:
- Molecular Biology
- Genetics
- Microbiology
Background:
- Bacteriophage lambda recombination is crucial for its life cycle.
- Understanding recombination mechanisms aids in genetic engineering and therapeutic applications.
- The P22 phage recombination system is essential for its propagation in Salmonella.
Purpose of the Study:
- To construct plasmids for controllable expression of lambda recombination proteins.
- To investigate the functional complementation of lambda and P22 recombination-deficient strains.
- To identify the minimal lambda recombination system capable of substituting for P22 functions.
Main Methods:
- Construction of plasmids encoding lambda recombination proteins (bet, exo, gam) at controllable levels.
- Transformation of Escherichia coli and Salmonella strains with these plasmids.
- Assessing the ability of expressed lambda functions to complement P22 and lambda mutants lacking essential recombination genes.
- Growth and recombination assays in recA- hosts.
Main Results:
- Plasmids expressing lambda recombination functions were successfully constructed.
- The lambda recombination proteins were functional in both E. coli and Salmonella hosts.
- The combination of lambda bet and exo proteins was sufficient to complement P22 recombination-deficient strains.
- Efficient growth and recombination were observed in recA- hosts utilizing the lambda bet/exo system.
Conclusions:
- Controllable expression of lambda recombination functions is achievable using engineered plasmids.
- The lambda bet and exo genes form a minimal functional unit that can replace the P22 recombination system.
- This finding has implications for understanding phage-host interactions and developing novel genetic tools.